Schmidt W A
Rheumaklinik Berlin-Buch, Karower Strasse 11, 13125 Berlin, Germany.
Z Rheumatol. 2003;62(Suppl 2):II54-6. doi: 10.1007/s00393-003-1216-1.
About 25% of administrations are for off-label indications. The treatment of many rheumatic diseases includes off-label use. Reimbursement from the health insurance is possible if no other approved therapy is available, and if scientific studies prove the effectiveness of the drug.
